Skip to main content

Sudan Luganathan

Analyst

Stevens

Equibles does not estimate personal net worth.

About Sudan Luganathan

Sudan Luganathan is recorded as Analyst at Stevens. Sudan Luganathan has spoken on 1 earnings call across 1 company, most recently for Kymera Therapeutics, Inc. on April 30, 2026. The companies whose calls Sudan Luganathan spoke on are classified in the Healthcare sector.

Sudan Luganathan on recent calls

“My question is on the 621 program for asthma and related downstream indications. You know, as we get our first look at asthma data in the late 2027, does that outcome dictate read-through and investment in going forward with COPD and other related indications?”
Analyst — Stevens, Kymera Therapeutics, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Stevens

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity